Complete References

Selected References for The Food-Mood Solution

Because of space limitations, the published edition of The Food-Mood Solution contains only a partial list of references. Here are the entire references (more than 200) for the book.

Preface

Grant BF, Stinson FS, Dawson DA, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders. Archives of General Psychiatry, 2004;61:807-816.

Kessler RC, Berglund P, Demler O, et al. Lifetime prevalence and age-of-onset distributions of DMS-IV disorders in the national comorbidity survey replication. Archives of General Psychiatry, 2005;62:593-602.

Kirby R. Mood swings and depression: let get to the bottom of it. Health Hunter newsletter, 2003;17:1,2,4.

McCook A. Many people need help with unhealthy relationships. Reuters Health news service, April 22, 2005.

Chapter 1

Benton D, Haller J, Fordy J. Vitamin supplementation for 1 year improves mood. Neuropsychobiology, 1995;32:98-105.

Caspi A, Sugden K, Moffitt TE, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science, 2003;301:386-389.

Cassata D. Rude behavior: it's a crass reality across hurried America, poll finds. Arizona Daily Star (Associated Press), October 15, 2005:A1

Gesch CB, Hammond SM, Hampson SE, et al. Influence of supplementary vitamins, minerals and essential fatty acids on the antisocial behavior of young adult prisoners. British Journal of Psychiatry, 2002;181:22-28.

Walsh WJ, Glab LB, Haakenson ML. Reduced violence behavior following biochemical therapy. Physiology & Behavior, 2004;82:835-839.

Chapter 2

Adler J. Take Out Nation. Newsweek, February 9, 2004:52-53.

Arnedt JT, Owens J, Crouch M, et al. Neurobehavioral performance of residents after heavy night call vs after alcohol ingestion. JAMA, 2005;294(:1025-1033.

Anon. 415 million vacation days won't be used. Arizona Daily Star, June 14, 2004:D3.

Ayas NT, White DP, Manson JE, et al. A prospective study of sleep duration and coronary heart disease in women. Archives of Internal Medicine, 2003;163:205-9.

Birnbaum SG, Yuan PX, Wang M, et al. Protein kinase C overactivity impairs prefrontal cortical regulation of working memory. Science, 2004;306(5697):882-884.

Black PH, Garbutt LD. Stress, inflammation and cardiovascular disease. Journal of Psychosomatic research, 2002;52:1-23.

Broadbent E, Petrie KJ, Alley PG, et al. Psychological stress impairs early wound repair following surgery. Psychosomatic Medicine, 2003;65:865-869.

Dallman MF, Pecoraro N, Akana SF, et al. Chronic stress and obesity: a new view of "comfort food." Proceedings of the National Academy of Sciences, 2003;100:11696-11701.

Dallman MF, Pecoraro NC, la Fleur SE. Chronic stress and comfort foods: self-medication and abdominal obesity. Brain, Behavior, and Immunity, 2005;19:275-280.

Elias M. Commuters' stress rolls into work. USA Today, August 7, 2003:1A.

Epel ES, Blackburn EH, Lin J, et al. Accelerated telomere shortening in response to life stress. Proceedings of the National Academy of Sciences, 2004;101: 17312-17315.

Flora C. Decaffination: the next disorder? Psychology Today, January/February 2005:21.

Goodman CK. Ground down by daily grind. Stress on job is common gripe of U.S. workers. Arizona Daily Star, April 18, 2005:D1.

Hairston IS, Little MT, Scanlon MD, et al. Sleep restriction suppresses neurogenesis induced by hippocampus-dependent learning. Journal of Neurophysiology, 2005;94:4224-4233.

Hakkarainen R, Johansson C, Kieseppa T, et al. Seasonal changes, sleep length and circadian preference among twins with bipolar disorder. BMC Psychiatry, 203;3:6-12.

Howarth E, Hoffman MS. A multidimensional approach to the relationship between mood and weather. British Journal of Psychology, 1984;75(Part 1):12-23.

Huerta PT, Kowal C, DeGiorgio LA, et al. Immunity and behavior: Antibodies alter emotion. Proceedings of the National Academy of Sciences, 2006:epub ahead of print. www.pnas.org/cgi/doi/10.1073/pnas.0510055103.

Keltikangas-Jarvinen L, Raikkonen K, Hautanen A, et al. Vital exhaustion, anger expression, and pituity and adrenocortical hormones. Implicatons for the insulin resistance syndrome. Arteriosclerosis Thrombosis and Vascular Biology, 1996;16:275-280.

Kiecolt-Glaser JK, Preacher KJ, MacCallum RC, et al. Chronic stress and age-related increases in the proinflammatory cytokine IL-6. Proceedings of the National Academy of Sciences, 2003;100:9090-9095.

Kiecolt-Glaser JK, Loving TJ, Stowell JR, et al. Hostile marital interactions, proinflammatory cytokine production, and wound healing. Archives of General Psychiatry, 2005;62:1377-1384.

McCook A. Stressful and insecure jobs take a toll on health. Reuters Health, November 21, 2003.

Oaten M, Cheng K. Academic examnation stress impairs self-control. Journal of Social and Clinical Psychology, 2005;24:254-279.

Rose B. Eight isn't enough in today's jobs. Arizona Daily Star, June 2, 2005:D1.

Saul S. Record sales of sleep pills cause worry. New York Times, February 7, 2006:A1

Schory TJ, Piecznski N, Nair S, et al. Barometic pressure, emergency psychiatric visits, and violent acts. Canadian Journal of Psychiatry, 2003;48:624-627.

Rosenkranz MA, Jackson DC, Dalton K, et al. Affective style and in vivo immune response: neurobehavioral mechanisms. Proceedings of the National Academy of Sciences, 2003; 100:11148-11152

Rozanski A, Blumenthal JA, Kaplan J. Impact of psychological factors on the pathogenesis of cardiovascular disease and implications for therapy. Circulation, 1999;99:2192-2217.

Schlesinger R. Is there life after work? AARP Bulletin, May 2005:3.

Wells AS, Read NW, Laugharne JD, et al. Alterations in mood after changing to a low-fat diet. British Journal of Nutrition, 1998;79:23-30.

Wertz AT, Wright KP, Ronda JM, et al. Effects of sleep inertia on cognition. JAMA, 2006;295:163-164.

Wessel H. 40-hour week is just a mirage for man now. Arizona Daily Star, November 24, 2003:D1.

Chapter 3

Cheraskin E. Human Health & Homeostasis. Birmingham, Alabama: Clayton College/Natural Reader Press: 1999.

Cox DJ, Kovatchev BP, Gonder-Frederick LA, et al. Relationships between hyperglycemia and cognitive performance among adults with type 1 and type 2 diabetes. Diabetes Care, 2005;28:71-77.

De Flora S, Grassi C, Carati L. Attenuation of influenza-like symptomatology and improvement of cell-mediated immunity with long-term N-acetylcysteine treatment. European Respiratory Journal, 1997;10:1535-1541.

Dodd ML, Klos KJ, Bower JH, et al. Pathological gambling caused by drugs used to treat Parkinson disease. Archives of Neurology, 2005;62:1-5.

Finger TE, Danilova V, Barrows J, et al. ATP signaling is crucial for communication from taste buds to gustatory nerves. Science, 2005;310:1495-1499.

Gesch CB, Hammnd SM, Hapson SE, et al. Influence of supplementary vitamins, minerals and essential fatty acids on the antiosocial behavior of young adult prisoners. British Journal of Psychiatry, 2002;181:22-28.

Kalivas P. Novel pharmacological approaches to the treatment of drug addiction: animal and human studies. Presented at the annual meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico, December 2005.

Leventhal AG, Wang Y, Pu M, et al. GABA and its antagonists improved visual cortical function in senescent monkeys. Science, 2003;300:812-815.

Walsh WJ, Glab LB, Haakenson, ML. Reduced violent behavior following biochemical therapy. Physiology & Behavior, 2004;82:835-839.

Chapter 4

Alpert JE, Papakostas G, Mischoulon D, et al. S-adenosyl-l-methionine (SAMe) as an adjunct for resistant major depressive disorder. Journal of Clinical Psychopharmacology, 2004;24:661-664.

Anonymous. DMG and obsessive-compulsive behaviors. Autism Research Review International, 1996;10:7.

Bell C, Abrams J, Nutt D. Tryptophan depletion and its implications for psychiatry. British Journal of Psychiatry, 2001;178:399-405.

Benjamin J, Agam G, Levine J, et al. Inositol treatment in psychiatry. Psychopharmacology Bulletin, 1995;31:167-175.

Benton D, Haller J, Fordy J. Vitamin supplementation for 1 year improves mood. Neuropsychobiology, 1995;32:98-105.

Benton D, Fordy J, Haller J. The impact of long-term vitamin supplementation on cognitive functioning. Psychopharmacology, 1995;117:298-305.

Benton D, Griffiths R, Haller J. Thiamine supplementation mood and cognitive functioning. Psychopharmacology, 1997;129:66-71.

Benton D, Donohoe RT, Sillance B, et al. The influence of phosphatidylserine supplementation on mood and heart rate when faced with an acute stressor. Nutritional Neuroscience, 2001;4:169-178.

Blusztajn JK. Choline, a vital amine. Nature, 1998;281:794-795.

Boeknke C, Reuter U, Flack U, et al. High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care center. European Journal of Neurology, 2004;11:475-477.

Brady JA, Rock CL, Horneffer MR. Thiamine status, diuretic medications, and the management of congestive heart failure. Journal of the American Dietetic Association, 1995;95:541-544.

Brenner R, Azbel V, Madhusoodanan S, et al. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind, randomized pilot study. Clinical Therapeutics, 2000;22:411-419.

Canty DJ, Zeisel SH. Lecithin and choline in human health and disease. Nutrition Reviews, 1994;52:327-339.

Carmel R. Current Concepts in cobalamin deficiency. Annual Review of Medicine, 2000;51:357-375.

Clancy J, Hoffer A, Lucy J, Osmond H, Smythies J & Stefaniak B:Design and planning in psychiatric research as illustrated by the Weyburn Chronic Nucleotide Project. Bulletin of the Menninger Clinic, 1954; 18:147-153.

Cooper R, Morre DJ, Morre DM. Medicinal benefits of green tea: part 1. Review of noncancer health benefits. Journal of Alternative and Complementary Medicine, 2005;11:521-528.

Elmadfa I, Majchrzak D, Rust P, et al. The thiamine status of adult humans depends on carbohydrate intake. International Journal for Vitamin and Nutrition Research, 2001;71:217-221

Eussen SJ, de Groot LC, Clarke R, et al. Oral cyanocobalamin supplementation in older people with vitamin B12 deficiency. Archives of Internal Medicine, 2005;165:1167-1172.

Fromm L, Heath DL, Vink R, et al. Magnesium attenuates post-traumatic depression/anxiety following diffuse traumatic brain injury in rats. Journal of the American College of Nutrition, 2004;23:529S-533S.

Fux M, Levine J, Aviv A, et al. Inositol treatment of obsessive-compulsive disorder. American Journal of Psychiatry, 1996;153:1219-1221.

Gannon MC, Nuttall JA, Nuttall FQ. The metabolic response to ingested glycine. American Journal of Clinical Nutrition, 2002;76:1302-1307.

Green P, Gispan-Herman I, Yadid G. Increased arachidonic acid concentration in the brain of Flinders Sensitive Line rats, an animal model of depression. Journal of Lipid Research, 2005;46:1093-1096.

Hallahan B, Garland MR. Essential fatty acids and their role in the treatment of impulsivity disorders. Prostaglandins, Leukotriences and Essential Fatty Acids, 2004;71:211-216.

Hamazaki T, Thienprasert A, Kheovichai K, et al. The effect of docosahexaenoic acid on aggression in elderly Thai subjects—a placebo-controlled double-blind study. Nutritional Neuroscience, 2002;5:37-41.

Iribarren C, Markovitz JH, Jacobs DR, et al. Dietary intake of n-3, n-6 fatty acids and fish: relationship with hostility in young adults—the CARDIA study. European Journal of Clinical Nutrition, 2004;58:24-31.

Jezova D, Makatsori A, Smriga M, et al. Subchronic treatment with amino acid mixture of L-lysine and L-arginine modifies neuroendocrine activation during psychosocial stress in subjects with high trait anxiety. Nutritional Neuroscience, 2005;8:155-160.

Kaplan BJ, Fisher JE, Crawford SG, et al. Improved mood and behavior during treatment with a mineral-vitamin supplement: an open label case series of children. Journal of Child and Adolescent Psychopharmacology, 2004;14:115-122.

Kennedy DO, Scholley AB, Wesnes KA. The dose-dependent cognitive effects of acute administration of Ginkgo biloba in healthy young volunteers. Psychopharmacology, 2000;151:416-423.

Levine M, Conry-Cantilena C, Wang Y, et al. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proceedings of the National Academy of Sciences, 1996;93:3704-3709.

Lustman PJ, Anderson RJ, Freedland KE, et al. Depression and poor glycemic control. Diabetes Care, 2000;23:934-942.

Leventhal AG, Wang Y, Pu M, et al. GABA and its antagonists improved visual cortical function in senescent monkeys. Science, 2003;300:812-815

Mason R. 200 mg of zen. L-theanine boosts alpha waves, promotes alert relaxation. Alternative & Complementary Therapies, 2001;7:91-95.

McLeod MN, Gaynes BN, Golden RN. Chromium potentiation of antidepressant pharmacology for dysthymic disorder in 5 patients. Journal of Clinical Psychiatry, 1999;60:237-240.

McLeod MN, Golden RN. Chromium treatment of depression. International Journal of Neuropsychopharmacology;2000;3:311-314.

Mousain-Bose M, Roche M, Rapin J, et al. Magnesium vitB6 intake reduces central nervous system hyperexcitability in children. Journal of the American College of Nutrition, 2004;23:545S-548S.

Palatnik A, Prolov K, Fux M, et al. Double-blind, controlled crossover trial of inositol versus fluvoxamine for the treatment of panic disorder. Journal of Clinical Psychopharmacology, 2001;21:335-339.

Penninx BWJH, Guralnik JM, Ferrucci L, et al. Vitamin B12 deficiency and depression in physically disabled older women: epidemiologic evidence from the women's health and aging study. American Journal of Psychiatry, 2000;157:715-721.

Philipp M, Kohnen R, Hiller KO. Hypericum extract versus imipramine or placebo in patients with moderate depression: randomized multicentre study of treatment for eight weeks. British Medical Journal, 1999;319:1534-1539.

Schrader E. Equivalence of St. John's wort extract (Ze 117) and fluoxetine: a randomized controlled study in mild-moderate depression. International Clinical Psychopharmacology, 2000;15:61-68.

Stevinson C, Ernst E. A pilot study of Hypericum perforatum for the treatment of premenstrual syndrome. British Journal of Obstetrics and Gynaecology, 2000;107:870-876.

Szegedi A, Kohnen R, Dienel A, et al. Acute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomized controlled double blind non-inferiority trial versus paraxetine. British Medical Journal, 2005;330:503-507.

Tildesley NTJ, Kennedy DO, Perry EK, et al. Positive modulation of mood and cognitive performance following administration of acute doses of Salvia lavandulaefolia essential oil to healthy young volunteers. Physiology & Behavior, 2005;83:699-709.

Watanabe CMH, Wolffram S, Ader P, et al. The in vivo neuromodulatory effects of the herbal medicine ginkgo biloba. Proceedings of the National Academy of Sciences, 2001;98:6577-6580

Wesnes KA, Ward T, McGinty A, et al. The memory enhancing effects of a Ginkgo biloba/Panax ginseng combination in healthy middle-aged volunteers. Psychopharmacology, 2000;152:353-361.

Wyatt KM, Simmock PW, Jones PW, et al. Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review. British Medical Journal, 1999;318:1375-1381.

Weber B, Schweigr U, Dueschle M, et al. Major depression and impaired glucose tolerance. Experimental and Clinical Endocrinology & Diabetes, 2000;108:187-190.

Woelk H, et al. Comparison of St. John's wort and imipramine for treating depression: randomized controlled trial. British Medical Journal, 2000;321:536-539.

Chapter 5

Vander Wal JS, Marth JM, Khosla P, et al. Short-Term Effect of Eggs on Satiety in Overweight and Obese Subjects. Journal of the American College of Nutrition, 2005; 24: 510-515.

Chapter 6

Ahlberg AC, Ljung T, Rosmond R, et al. Depression and anxiety symptoms in relation to anthropometry and metabolism in men. Psychiatry Research, 2002;112:101-110.

Antunes HK, Stella SG, Santos RF, et al. Depression, anxiety and quality of life scores in seniors after an endurance exercise program. Revista Brasileira de Psiquiatra, 2005;27:266-271.

Blumenthal JA, Babyak MA, Moore KA, et al. Archives of Internal Medicine, 1999;159:2349-2356.

Dunn AL, Trivedi MH, Kampert JB, et al. Exercise treatment for depression: efficacy and dose response. American Journal of Preventive Medicine, 2005;28:1-8

Gaul-Alcacova P. Boucek J, Stejskal P, et al. Assessment of the influence of exercise on heart rate variability in anxiety patients. Neuro Endocrinology Letters;December 28, 2005;26:epub ahead of print.

Nabkasorn C, Miyai N, Sootmongkol A, et al. Effects of physical exercise on depression: neuroendocrine stress hormones and physiological fitness in adolescent females with depressive symptoms. European Journal of Public Health, August 26, 2005:epub ahead of print.

Stella SG, Vilar AP, Lacrois C, et al. Effects of type of physical exercise and leisure activities on the depression scores of obese Brazilian adolescent girls. Brazilian Journal of Medical and Biological Research, 2005;38:1683-1689.

Stewart KJ, Turner KL, Bacher AC, et al. Are fitness, activity, and fatness associated with health-related quality of life and mood in older persons? Journal of Cardiopulmonary Rehabilitation, 2003;23:115-121.

Chapter 7

Anonymous. Doctors: sooth harp music may help an arrhythmic heart. Arizona Daily Star (Associated Press), December 26, 2005:A2.

Arnedt JT, Wilde GJS, Munt PW, et al. How do prolonged wakefulness and alcohol compare in the decrements they produce on a simulated driving task. Accident Analysis and Prevention, 2001;33:337-344.

Arnedt TJ, Owens J, Crouch M, et al. Neurobehavioral performance of residents after heavy night call vs after alcohol ingestion. JAMA, 2005;294:1025-1033.

Berk LS, Tan SA, Fry WF, et al. Neuroendocrine and stress hormone changes during mirthful laughter. American Journal of Medical Sciences, 1989;298:390-396.

Berk LS, Felten DL, Tan SA, et al. Modulation of neuroimmune parameters during the eustress of humor-associated mirthful laughter. Alternative Therapies in Health and Medicine, 2001;7:62-72,74-76.

Kozorovitskiy Y, Gross CG, Kopil C, et al. Experience induces structural and biochemical changes in the adult primate brain. Proceedings of the National Academy of Sciences, 2005; doi/10.1073/pnas.0508817102.

Mason R. The sound medicine of Brian Dailey, M.D., F.A.C.E.P.Journal of Alternative & Complementary Therapies, 2004;10:156-160.

Rossi EL. Sacred spaces and places in healing dreams: gene expression and brain growth in rehabilitation. Psychological Perspectives, 2004;47:48-63.

Rossi EL. Psychosocial genomics: gene expression, neurogenesis, and human experience in mind-body medicine. Advances in Body-Mind Medicine, 2002;18:22-30.

Smyth JM, Stone AA, Hurewitz A, et al. Effects of writing about stressful experiences on symptom reduction in patients with asthma or rheumatoid arthritis: a randomized trial. JAMA, 1999;281:1304-1309.

Willich SN, Wegscheider K, Stallmann M, et al. Noise burden and the risk of myocardial infarction. European Heart Journal, 2005; Epub ahead of print.

Chapter 8

Benton D, Haller J, Fordy J. Vitamin supplementation for 1 year improves mood. Neuropsychobiology, 1995;32:98-105.

Bertone-Johnson ER, Hankinson SE, Bendich A, et al. Calcium and vitamin D intake and risk of incident premenstrual syndrome. Archives of Internal Medicine, 2005;165:1246-1252.

Das UN. Perinatal supplementation of long-chain polyunsaturated fatty acids, immune response and adult disease. Medical Science Monitor, 2004;10:HY19-Hy25.

Keltikangas-Jarvinen L, Raikkonen K, Hautanen A, et al. Vital exhaustion, anger expression, and pituitary and adrenocorticol hormones. Arteriosclerosis, Thrombosis and Vascular Research, 1996;16:275-280.

Keltikangas-Jarvinen L, Ravaja N, Raikkonen K, et al. Relationships between the pituitary-adrenal hormones, insulin, and glucose in middle-aged men: moderating influence of psychosocial stress. Metabolism, 1998;47:1440-1449.

Ljung T, Holm G, Friberg P, et al. The activity of the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system in relation to waist/hip circumference ratio in men. Obesity Research, 2000;8:487-495.

Stevinson C, Ernst E. A pilot study of Hypericum perforatum for the treatment of premenstrual syndrome. British Journal of Obstetrics and Gynaecology, 2000;107:870-876.

Sekine Y, Ouchi Y, Takei N, et al. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Archives of General Psychiatry, 2006;63:90-100.

Wells AS, Read NW, Laugharne JDE, et al. Alterations in mood after changing to a low-fat diet. British Journal of Nutrition, 1998;79:23-30.

Walsh WJ, Glab LB, Haakenson ML. Reduced violence behavior following biochemical therapy. Physiology & Behavior, 2004;82:835-839.

Young SN, Leyton M. The role of serotonin in human mood and social interaction. Insight from altered tryptophan levels. Pharmacology, Biochemistry, and Behavior, 2002;71:857-865.

Chapter 9

Ahlberg AC, Ljung T, Rosmond R, et al. Depression and anxiety symptoms in relation to anthropometry and metabolism in men. Psychiatry Research, 2002;112:101-110.

Alberti KG, Nattrass M. Lactic acidosis. Lancet, 1977;2(8027):25-29.

Anonymous. Study: 30% of GIs have stress after duty in Iraq. Arizona Daily Star, July 29, 2005:A13.

Atmaca M, Tezcan E, Kuloglu M, et al. Serum folate and homocysteine in patients with obsessive-compulsive disorder. Psychiatry and Clinical Neurosciences, 2005;59:616-620.

Benjamin J, Levine J, Fux M, et al. Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder. American Journal of Psychiatry, 1995;152:1084-1086.

Elmadfa I, Majchrzak D, Rust P, et al. The thiamine status of adult humans depends on carbohydrate intake. International Journal for Vitamin and Nutrition Research, 2001;71:217-221.

Fux M, Levine J, Aviv A, et al. Inositol treatment of obsessive-compulsive disorder. American Journal of Psychiatry, 1996;153:1219-1221.

Gannon MC, Nuttall JA, Nuttall FQ. The metabolic response to ingested glycine. American Journal of Clinical Nutrition, 2002;76:1302-1307.

Gomez-Caminero A, Blumentals WA, Russo LJ, et al. Does panic disorder increase the risk of coronary heart disease? A cohort study of a national managed care database. Psychosomatic Medicine, 2005;67(5):688-691.

Gundersen RY, Vaagenes P, Breivik T, et al. Glycine--an important neurotransmitter and cytoprotective agent. Acta Anaesthesiologica Scandinavica, 2005;49:1108-1116.

Hoge CW, Castro CA, Messer SC, et al. Combat duty in Iraq and Afghanistan, mental health problems, and barriers to care. New England Journal of Medicine, 2004;351:13-22

Hughes JR, Higgins ST, Bickel WK, et al. Caffeine self-administration, withdrawal, and adverse effects among coffee drinkers. Archives of General Psychiatry, 1991;48:611-617.

Lafleur DL, Pittenger C, Kelmendi B, et al. N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder. Psychopharmacology, 2006;184:254-256.

Leahy R. The Way of the Worrier. Psychology Today, December 2005:68-72

Mills DE, Prkachin KM, Harvey KA, et al. Dietary fatty acid supplementation alters stress reactivity and performance in man. Journal of Human Hypertension, 1989;3:111-116.

Palatnik A, Frolov K, Fux M, et al. Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder. Journal of Clinical Psychopharmacology, 2001;21:335-339.

Pittenger C, Krystal JH, Coric V. Initial evidence of the beneficial effects of glutamate-modulating agents in the treatment of self-injurious behavior associated with borderline personality disorder. Journal of Clinical Psychiatry, 2005;66(11):1492-1493.

Pitts FN Jr, McClure JN. Lactate metabolism in anxiety neurosis. New England Journal of Medicine, 1967;277:1329-1336.

Prousky JE. Supplemental niacinamide mitigates anxiety symptoms: three case reports. Journal of Orthomolecular Medicine, 2005;20:167-178.

Saxbe D. Panic attacks—the fear of fear itself. Psychology Today, December 2005:28.

Seelig MS, Berger AR, Spielholz N. Latent tetany and anxiety, marginal magnesium deficit, and normocalcemia. Diseases of the Nervous System, 1975;36:461-465.

Schrader E. Equivalence of St. John's wort extract (Ze 117) and fluoxetine: a randomized controlled study in mild-moderate depression. International Clinical Psychopharmacology, 2000;15:61-68.

Warner M. A jolt of caffine, by the can. Energy drinks are the rage, but are some youths hooked? New York Times, November 23, 2005:C1.

Wells AS, Read NW, Laugharne JDE, et al. Alterations in mood after changing to a low-fat diet. British Journal of Nutrition, 1998;79:23-30.

Chapter 10

Anonymous. Parkinson's drug linked to compulsive behavior. Arizona Daily Star (Associated Press), July 12, 2005:A2.

Dodd ML, Klos KJ, Bower JH, et al. Pathological gambling caused by drugs used to treat Parkinson disease. Archives of Neurology, 2005;62:1-5.

Elmadfa I, Majchrzak D, Rust P, et al. The thiamine status of adult humans depends on carbohydrate intake. International Journal for Vitamin and Nutrition Research, 2001;71:217-221.

Hallahan B, Garland MR. Essential fatty acids and their role in the treatment of impulsivity disorders. Prostaglandins, Leukotrienes and Essential Fatty Acids, 2004;71:211-216.

Henig RM. Driving? Maybe you shouldn't be reading this. New York Times, July 13, 2005:D5.

Irvine M. Internet generation riding technological wave into the future. Arizona Daily Star (Associated Press), December 5, 2005:A1.

Kershaw S. Hooked on the web: help is on the way. New York Times, December 1, 2005:E1.

Leventhal AG, Wang Y, Pu M, et al. GABA and its antagonists improved visual cortical function in senescent monkeys. Science, 2003;300:812-815.

Maayan R, Lotan S, Doron R, et al. dehydroepiandrosterone (DHEA) attenuated cocaine-seeking behavior in the self-administration model in rats. European Neuropsychopharmacology, 2005: November 22 epub ahead of print.

Matsuoka Y, Furuyashiki T, Yamada K, et al. Prostaglandin E receptor EP1 controls impulsive behavior under stress. Proceedings of the National Academy of Sciences, 2005;102:16066-16071.

McGough JJ, Smalley SL, McCracken JT, Psychiatric comorbidity in adult attention deficit hyperactivity disorder: findings from multiplex families. American Journal of Psychiatry, 2005;162:1621-1627.

Mousain-Bosc M, Roche M, Rapin J, et al. Magnesium vitB6 intake reduces central nervous system hyperexcitability in children. Journal of the American College of Nutrition, 2004;23:545S-548S.

Richardson AJ, Montgomery P. The Oxford-Durham study: a randomized, controlled trial of dietary supplementation with fatty acids in children with developmental coordination disorder. Pediatrics, 2005;115:1360-1366.

Saugstad LR. A "new-old" way of thinking about brain disorder, cerebral excitability—the fundamental property of nervous tissue. Medical Hypotheses, 2005;64:142-150.

Seven R. Life interrupted. Plugged into it all, we're stressed to distraction. Pacific Northwest, the Seattle Times Magazine, November 28, 2004: http://seattletimes.nwsource.com/pacificnw/2004/1128/cover.html

Parker-Pope T. Why shopping makes you feel so good. Phoenix Republic (Wall Street Journal news service), December 6, 2005.

Tyre P. A problem in the brain. ADHD medicine is not just for children anymore. Newsweek, 2005;October 17, 2005:61.

Chapter 11

Davidson JR, Abraham K, Connor KM, et al. Effectiveness of chromium in atypical depression: a placebo-controlled trial. Biological Psychiatry, 2003;53:261-4.

Khan A, Safdar M, Khan MMA, et al. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care, 2003; 26:3215-3218.

Kim MS, Park JY, Namkoong C, et al. Anti-obesity effects of a-lipoic acid mediated by suppression of hypothalamic AMP-activated protein kinase. Nature Medicine, 2004;10:727-733.

McLeod MN, Golden RN. Chromium treatment of depression. International Journal of Neuropsychopharmacology;2000;3:311-314.

McLeod MN, Gaynes BN, Golden RN. Chromium potentiation of antidepressant pharmacology for dysthymic disorder in 5 patients. Journal of Clinical Psychiatry, 1999;60:237-240.

Ogawa N, Satsu H, Watanabe H, et al. Acetic acid suppresses the increase in disaccharidase activity that occurs during culture of caco-2 cells. Journal of Nutrition, 2000;130:507-513.

Velussi M, Cernigoi AM, De Monte AD, et al. Long-term (12 months) treatment with an antioxidant drug (silymarin) is effective on hyperinsulinemia, exogenous insulin need and malondialdehyde levels in cirrhotic diabetic patients. Journal of Hepatology, 1997;26:871-879.

Vuksan V, Sievenpiper JL, Koo VYY, et al. American ginseng (panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitus. Archives of Internal Medicine, 2000;160:1009-1013.

Vuksan V, Stavro MP, Sievenpiper JL, et al. American ginseng improves glycemia in individuals with normal glucose tolerance: effect of dose and time escalation. Journal of the American College of Nutrition, 2000;19:738-744.

Vuksan V, Sievenpiper JL, Wong J, et al. American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals. American Journal of Clinical Nutrition, 2001;73:753-758.

Chapter 12

Alpert JE, Papakostas G, Mischoulon D, et al. S-adenosyl-L-methionine (SAMe) as an adjunct for resistant major depressive disorder. Journal of Clinical Psychopharmacology, 2004;24:771-664.

Bartholomew JB, Morrison D, Ciccolo JT, et al. Effects of acute exercise on mood and well-being in patients with major depressive disorder. Medicine and Science in Sports and Exercise, 2005;37:2032-2037.

Das AK, Olfson M, Gameroff MJ, et al. Scrreening for bipolar disorder in a primary care practice. JAMA, 2005;293:956-963.

Delle Chiaie R, Pancheri P, Scapicchio P. Efficacy and tolerability of oral and intramuscular S-adenosyl-L-methionine 1,4-butanedisulfonate (SAMe) in the treatment of major depression: comparison with imipramine in 2 multicenter studies. American Journal of Clinical Nutrition, 2002;76:1172S-1176S.

Docherty JP, Sack DA, Roffman M, et al. A double-blind, placebo-controlled, exploratory trial of chromium picolinate in atypical depression: effect on carbohydrate craving. Journal of Psychiatric Practice, 2005;11:302-314.

Gastpar M, Zeller K. Comparison of hypericum extract STW3 and sertraline in the treatment of moderate depression: a double-blind randomized 24-week-study. Psychopharmakotherapie, 2005;12:146-153.

Hirashima F, Parow AM, Stoll AL, et al. Omega-3 fatty acid treatment and T2 whole brain relaxation times in bipolar disorder. American Journal of Psychiatry, 2004;161:1922-1924.

Kaplan BJ, Simpson SA, Ferre RC, et al. Effective mood stabilization with a chelated mineral supplement: an open-label trial in bipolar disorder. Journal of Clinical Psychiatry, 2001;62:936-944.

McLeod MN, Gaynes BN, Golden RN. Chromium potentiation of antidepressant pharmacology for dysthymic disorder in 5 patients. Journal of Clinical Psychiatry, 1999;60:237-240.

McLeod MN, Golden RN. Chromium treatment of depression. International Journal of Neuropsychopharmacology;2000;3:311-314.

Mischoulon D, Fava M. Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence. Am J Clin Nutr, 2002;76(5):1158s-1161S.

Nemets H, Nemets B, Apter A, et al. Omega-3 treatment of childhood depression: a controlled, double-blind study. American Journal of Psychiatry, 2006;163:1098-1100.

Parker G, Gibson NA, Brotchie H, et al. Omega-3 fatty acids and mood disorders. American Journal of Psychiatry, 2006;163:969-978.

Schrader E. Equivalence of St. John's wort extract (Ze 117) and fluoxetine: a randomized controlled study in mild-moderate depression. International Clinical Psychopharmacology, 2000;15:61-68.

Schmidt PJ, Daly RC, Bloch M, et al. dehydroepiandrosterone monotherapy in midlife-onset major and minor depression. Archives of General Psychiatry, 2005;62:154-162.

Stoll AL, Severus E, Freeman MP, et al. Omega-3 fatty acids in bipolar disorder. Archives of General Psychiatry, 1999;56:407-412.

Sublette ME, Hibbeln JO, Galfalvy H, et al. Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. American Journal of Psychiatry, 2006;163:100-1102.

Stevinson C, Ernst E. A pilot study of Hypericum perforatum for the treatment of premenstrual syndrome. British Journal of Obstetrics and Gynaecology, 2000;107:870-876.

Woelk H, et al. Comparison of St. John's wort and imipramine for treating depression: randomized controlled trial. British Medical Journal, 2000;321:536-539.

Chapter 13

Kim H, Jhoo, Shin E, et al. Selenium deficiency potentiates methamphetamine-induced nigral neuronal loss; comparison with MPTP model. Brain Research, 2000;862:247-252.

Lafleur DL, Pittenger C, Kelmendi B, et al. N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder. Psychopharmacology, 2006;184:254-256.

Lauritzen I, Blondeau, Heurteaux C, et al. Polyunsaturated fatty acids are potent neuroprotectors. EMBO Journal, 2000;19:1784-1793.

Sekine Y, Ouchi Y, Takei N, et al. Brain serotonin transporter density and aggression in abstinent methamphetamine abusers. Archives of General Psychiatry, 2006;63:90-100.

Virmani A, Gaetani F, Binienda Z. Effects of metabolic modifiers such as carnitines, coenzyme Q10, and PUFAs against different forms of neurotoxic insulins: metabolic inhibitors, MPTP, and methamphetamine. Annals of the New York Academy of Sciences, 2005;1053:183-191.